Speaking to BBC Radio 4’s Today programme, Mr Streeting reiterated that the NHS “isn’t on the table” in terms of trade discussions, but said the UK has a “large and diverse patient population” that could offer a lot in terms of research.
He said: “We’ve always been clear that the NHS isn’t on the table, but if I think about the ingredients that are key to the NHS’s success, particularly in terms of life sciences and medical technology, there’s a lot that we’ve got to offer the United States and there’s a lot that we could get from the United States given our two countries’ strengths.”.
Asked what the UK could contribute, he said: “We’ve got great science, we’ve got a large and diverse patient population that in terms of medical research and clinical trials has a lot to offer the world.”.
Wes Streeeting has said that the health service is “not up for grabs”, but suggested the UK has a “large and diverse patient population” that could offer a lot in terms of research.
Donald Trump has said that the UK and the US could end up with a “real trade deal” that would make tariffs unnecessary, and called Sir Keir Starmer a “tough negotiator” in trying to persuade him not to introduce tariffs.
